Cardiac Pathways FDA clearance:
This article was originally published in Clinica
Executive Summary
Cardiac Pathways has received US FDA 510(K) clearance to begin marketing its RPM (real-time position management) tracking system. It is intended for use in most diagnostic electrophysiology procedures for real-time visualisation of catheters and is expected to assist physicians in precisely manipulating catheters within the heart during procedures, offering the potential for reductions in procedure times, the Sunnyvale, California-based company said.